Finance

Lists
JBIO:NASDAQ
Jade Biosciences Inc
US$13,77
-1,64%
(-0,23) 1D
13 ຕ.ລ., 12 ໂມງ 41 ນາທີ 49 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JBIO...
Open
US$14,00
High
US$14,24
Low
US$13,35
Mkt. cap
875,74 ລ້ານ
Avg. vol.
1,01 ລ້ານ
Volume
548,39 ພັນ
52-wk high
US$27,96
52-wk low
US$8,36
EPS
US$-2,31
Beta
1,64
Shares outstanding
63,60 ລ້ານ
No. of employees
55
Open
US$14,00
High
US$14,24
Low
US$13,35
Mkt. cap
875,74 ລ້ານ
Avg. vol.
1,01 ລ້ານ
Volume
548,39 ພັນ
52-wk high
US$27,96
52-wk low
US$8,36
EPS
US$-2,31
Beta
1,64
Shares outstanding
63,60 ລ້ານ
No. of employees
55
News stories
From web sources and news partners
巴士的報
巴士的報
·
27 ນາທີກ່ອນ
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
Bloomberg.com
Bloomberg.com
·
2 ຊົ່ວໂມງກ່ອນ
S&P 500 Record Rally Meets Risk of Peaking Earnings Growth
About Jade Biosciences Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Analyst ratings
Based on 10 analysts giving stock ratings to JBIO in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for JBIO in the last 3 months.
Highest
Current US$13,77
US$77,00 (+459,19%)
Average
US$50,50 (+266,74%)
Lowest
US$40,00 (+190,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
US$47,00
+241,3%
10/01/2026
David Nierengarten
Wedbush
Buy
Maintained
US$47,00
+241,3%
10/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
US$55,00
+299,4%
10/01/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/30/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
US$42,00
+205%
09/30/2026
Kaveri Pohlman
Clear Street
Buy
Reiterated
US$48,00
+248,6%
09/04/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$40,00
+190,5%
08/13/2026
Akash Tewari
Jefferies
Buy
Maintained
US$48,00
+248,6%
08/11/2026
Laura Chico
Wedbush
Buy
Maintained
US$47,00
+241,3%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
US$77,00
+459,2%
08/10/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/10/2026
Michael Yee
UBS
Buy
Initiated
US$45,00
+226,8%
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,01 ລ້ານ
28,54 ລ້ານ
36,05 ລ້ານ
50,06 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 ລ້ານ
6,44 ລ້ານ
7,39 ລ້ານ
8,85 ລ້ານ
Operating expense
27,40 ລ້ານ
34,98 ລ້ານ
43,44 ລ້ານ
58,92 ລ້ານ
Total operating expenses
27,40 ລ້ານ
34,98 ລ້ານ
43,44 ລ້ານ
58,92 ລ້ານ
Operating income
-27,40 ລ້ານ
-34,98 ລ້ານ
-43,44 ລ້ານ
-58,92 ລ້ານ
Other non operating income
-28,00 ພັນ
20,00 ພັນ
-9,00 ພັນ
-62,00 ພັນ
EBT including unusual items
-25,18 ລ້ານ
-31,87 ລ້ານ
-40,35 ລ້ານ
-55,75 ລ້ານ
EBT excluding unusual items
-25,18 ລ້ານ
-31,87 ລ້ານ
-40,35 ລ້ານ
-55,75 ລ້ານ
Income tax expense
-
58,00 ພັນ
16,00 ພັນ
15,00 ພັນ
Effective tax rate
-
-0,18%
-0,04%
-0,03%
Other operating expenses
-
-
-
-
Net income
-25,18 ລ້ານ
-31,93 ລ້ານ
-40,37 ລ້ານ
-55,76 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0,76
Interest and investment income
2,25 ລ້ານ
3,08 ລ້ານ
3,10 ລ້ານ
3,23 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
2,25 ລ້ານ
3,08 ລ້ານ
3,10 ລ້ານ
3,23 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,39 ລ້ານ
-34,97 ລ້ານ
-43,44 ລ້ານ
-58,91 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google